(19)
(11) EP 4 225 235 A1

(12)

(43) Date of publication:
16.08.2023 Bulletin 2023/33

(21) Application number: 21878692.9

(22) Date of filing: 11.10.2021
(51) International Patent Classification (IPC): 
A61F 9/007(2006.01)
(52) Cooperative Patent Classification (CPC):
A61F 9/0017; A61B 17/3421
(86) International application number:
PCT/US2021/054395
(87) International publication number:
WO 2022/076938 (14.04.2022 Gazette 2022/15)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 09.10.2020 US 202063089829 P
19.11.2020 US 202063115654 P

(71) Applicants:
  • Clearside Biomedical, Inc.
    Alpharetta, Georgia 30005 (US)
  • Hope, Jay
    Nashville, TN 37204 (US)
  • Mykleby, Jordan
    Nashville, TN 37216 (US)
  • Garbin, Nicolo
    Houston, TX 77005 (US)

(72) Inventors:
  • WAN, Chen-rei
    Alpharetta, Georgia 30005 (US)
  • ANDINO, Rafael Victor
    Alpharetta, Georgia 30005 (US)
  • PRICKETT, Clay G.
    Alpharetta, Georgia 30005 (US)
  • HOPE, Jay
    Nashville, Tennessee 37204 (US)
  • MYKLEBY, Jordan
    Nashville, Tennessee 37216 (US)
  • GARBIN, Nicolo
    Houston, Texas 77005 (US)

(74) Representative: Cooley (UK) LLP 
22 Bishopsgate
London EC2N 4BQ
London EC2N 4BQ (GB)

   


(54) APPARATUS AND METHODS OF RETINAL INJECTION